PSYCH Investor Summit: Research & Development
Four weeks until the upcoming PSYCH Investor Summit: Research & Development remain, and we’re pleased to announce the latest speakers in the programming:
Dr. Ben Sessa
Chief Medical Officer
Awakn Life Sciences
Contextualised by the current research by the Awakn Life Sciences team, Dr. Sessa will highlight the condition of addiction and the potential of psychedelics as a treatment option.
Dr. Jennifer Mitchell
Professor of Neurology & Psychiatry
University of California San Francisco
Lead author of MAPS’ recent peer-reviewed paper which outlines results of its Phase 3 clinical trial, Dr. Mitchell will outline the condition of PTSD and how MDMA may help treat it.
Founder of the world’s leading repository for clinical research data, operator listings, intelligence and insight on psychedelic medicines, Floris will share a summary of ongoing clinical research by operators around the world.
Secure your seat today and join us on 7 July for these can’t-miss speakers.Register Now